Global MRD (Minimal Residual Disease) Testing Market Insights, Forecast to 2028
SKU ID : QYR-20431945 | Publishing Date : 08-Mar-2022
Detailed TOC of Global MRD (Minimal Residual Disease) Testing Market Insights, Forecast to 2028
1 Study Coverage1.1 MRD (Minimal Residual Disease) Testing Product Introduction
1.2 Market by Type
1.2.1 Global MRD (Minimal Residual Disease) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Flow Cytometry
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Next-Generation Sequencing (NGS)
1.3 Market by Application
1.3.1 Global MRD (Minimal Residual Disease) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Specialty Clinics and Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global MRD (Minimal Residual Disease) Testing Sales Estimates and Forecasts 2017-2028
2.2 Global MRD (Minimal Residual Disease) Testing Revenue Estimates and Forecasts 2017-2028
2.3 Global MRD (Minimal Residual Disease) Testing Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global MRD (Minimal Residual Disease) Testing Sales by Region
2.4.1 Global MRD (Minimal Residual Disease) Testing Sales by Region (2017-2022)
2.4.2 Global Sales MRD (Minimal Residual Disease) Testing by Region (2023-2028)
2.5 Global MRD (Minimal Residual Disease) Testing Revenue by Region
2.5.1 Global MRD (Minimal Residual Disease) Testing Revenue by Region (2017-2022)
2.5.2 Global MRD (Minimal Residual Disease) Testing Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global MRD (Minimal Residual Disease) Testing Sales by Manufacturers
3.1.1 Global Top MRD (Minimal Residual Disease) Testing Manufacturers by Sales (2017-2022)
3.1.2 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of MRD (Minimal Residual Disease) Testing in 2021
3.2 Global MRD (Minimal Residual Disease) Testing Revenue by Manufacturers
3.2.1 Global MRD (Minimal Residual Disease) Testing Revenue by Manufacturers (2017-2022)
3.2.2 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by MRD (Minimal Residual Disease) Testing Revenue in 2021
3.3 Global MRD (Minimal Residual Disease) Testing Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global MRD (Minimal Residual Disease) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global MRD (Minimal Residual Disease) Testing Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global MRD (Minimal Residual Disease) Testing Sales by Type
4.1.1 Global MRD (Minimal Residual Disease) Testing Historical Sales by Type (2017-2022)
4.1.2 Global MRD (Minimal Residual Disease) Testing Forecasted Sales by Type (2023-2028)
4.1.3 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028)
4.2 Global MRD (Minimal Residual Disease) Testing Revenue by Type
4.2.1 Global MRD (Minimal Residual Disease) Testing Historical Revenue by Type (2017-2022)
4.2.2 Global MRD (Minimal Residual Disease) Testing Forecasted Revenue by Type (2023-2028)
4.2.3 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028)
4.3 Global MRD (Minimal Residual Disease) Testing Price by Type
4.3.1 Global MRD (Minimal Residual Disease) Testing Price by Type (2017-2022)
4.3.2 Global MRD (Minimal Residual Disease) Testing Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global MRD (Minimal Residual Disease) Testing Sales by Application
5.1.1 Global MRD (Minimal Residual Disease) Testing Historical Sales by Application (2017-2022)
5.1.2 Global MRD (Minimal Residual Disease) Testing Forecasted Sales by Application (2023-2028)
5.1.3 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028)
5.2 Global MRD (Minimal Residual Disease) Testing Revenue by Application
5.2.1 Global MRD (Minimal Residual Disease) Testing Historical Revenue by Application (2017-2022)
5.2.2 Global MRD (Minimal Residual Disease) Testing Forecasted Revenue by Application (2023-2028)
5.2.3 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028)
5.3 Global MRD (Minimal Residual Disease) Testing Price by Application
5.3.1 Global MRD (Minimal Residual Disease) Testing Price by Application (2017-2022)
5.3.2 Global MRD (Minimal Residual Disease) Testing Price Forecast by Application (2023-2028)
6 North America
6.1 North America MRD (Minimal Residual Disease) Testing Market Size by Type
6.1.1 North America MRD (Minimal Residual Disease) Testing Sales by Type (2017-2028)
6.1.2 North America MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2028)
6.2 North America MRD (Minimal Residual Disease) Testing Market Size by Application
6.2.1 North America MRD (Minimal Residual Disease) Testing Sales by Application (2017-2028)
6.2.2 North America MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2028)
6.3 North America MRD (Minimal Residual Disease) Testing Market Size by Country
6.3.1 North America MRD (Minimal Residual Disease) Testing Sales by Country (2017-2028)
6.3.2 North America MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe MRD (Minimal Residual Disease) Testing Market Size by Type
7.1.1 Europe MRD (Minimal Residual Disease) Testing Sales by Type (2017-2028)
7.1.2 Europe MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2028)
7.2 Europe MRD (Minimal Residual Disease) Testing Market Size by Application
7.2.1 Europe MRD (Minimal Residual Disease) Testing Sales by Application (2017-2028)
7.2.2 Europe MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2028)
7.3 Europe MRD (Minimal Residual Disease) Testing Market Size by Country
7.3.1 Europe MRD (Minimal Residual Disease) Testing Sales by Country (2017-2028)
7.3.2 Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific MRD (Minimal Residual Disease) Testing Market Size by Type
8.1.1 Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Type (2017-2028)
8.1.2 Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2028)
8.2 Asia Pacific MRD (Minimal Residual Disease) Testing Market Size by Application
8.2.1 Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Application (2017-2028)
8.2.2 Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2028)
8.3 Asia Pacific MRD (Minimal Residual Disease) Testing Market Size by Region
8.3.1 Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Region (2017-2028)
8.3.2 Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America MRD (Minimal Residual Disease) Testing Market Size by Type
9.1.1 Latin America MRD (Minimal Residual Disease) Testing Sales by Type (2017-2028)
9.1.2 Latin America MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2028)
9.2 Latin America MRD (Minimal Residual Disease) Testing Market Size by Application
9.2.1 Latin America MRD (Minimal Residual Disease) Testing Sales by Application (2017-2028)
9.2.2 Latin America MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2028)
9.3 Latin America MRD (Minimal Residual Disease) Testing Market Size by Country
9.3.1 Latin America MRD (Minimal Residual Disease) Testing Sales by Country (2017-2028)
9.3.2 Latin America MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa MRD (Minimal Residual Disease) Testing Market Size by Type
10.1.1 Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Type (2017-2028)
10.1.2 Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2028)
10.2 Middle East and Africa MRD (Minimal Residual Disease) Testing Market Size by Application
10.2.1 Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Application (2017-2028)
10.2.2 Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2028)
10.3 Middle East and Africa MRD (Minimal Residual Disease) Testing Market Size by Country
10.3.1 Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Country (2017-2028)
10.3.2 Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 ICON plc
11.1.1 ICON plc Corporation Information
11.1.2 ICON plc Overview
11.1.3 ICON plc MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 ICON plc MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ICON plc Recent Developments
11.2 ArcherDX(Invitae)
11.2.1 ArcherDX(Invitae) Corporation Information
11.2.2 ArcherDX(Invitae) Overview
11.2.3 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 ArcherDX(Invitae) Recent Developments
11.3 ARUP Laboratories
11.3.1 ARUP Laboratories Corporation Information
11.3.2 ARUP Laboratories Overview
11.3.3 ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ARUP Laboratories Recent Developments
11.4 Asuragen
11.4.1 Asuragen Corporation Information
11.4.2 Asuragen Overview
11.4.3 Asuragen MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Asuragen MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Asuragen Recent Developments
11.5 Cergentis B.V.
11.5.1 Cergentis B.V. Corporation Information
11.5.2 Cergentis B.V. Overview
11.5.3 Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cergentis B.V. Recent Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Corporation Information
11.6.2 Bio-Rad Laboratories Overview
11.6.3 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bio-Rad Laboratories Recent Developments
11.7 Mission Bio
11.7.1 Mission Bio Corporation Information
11.7.2 Mission Bio Overview
11.7.3 Mission Bio MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mission Bio MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mission Bio Recent Developments
11.8 Guardant Health
11.8.1 Guardant Health Corporation Information
11.8.2 Guardant Health Overview
11.8.3 Guardant Health MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Guardant Health MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Guardant Health Recent Developments
11.9 Invivoscribe
11.9.1 Invivoscribe Corporation Information
11.9.2 Invivoscribe Overview
11.9.3 Invivoscribe MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Invivoscribe MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Invivoscribe Recent Developments
11.10 LabCorp
11.10.1 LabCorp Corporation Information
11.10.2 LabCorp Overview
11.10.3 LabCorp MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 LabCorp MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 LabCorp Recent Developments
11.11 Inivata
11.11.1 Inivata Corporation Information
11.11.2 Inivata Overview
11.11.3 Inivata MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Inivata MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Inivata Recent Developments
11.12 Natera
11.12.1 Natera Corporation Information
11.12.2 Natera Overview
11.12.3 Natera MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Natera MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Natera Recent Developments
11.13 NeoGenomics Laboratories
11.13.1 NeoGenomics Laboratories Corporation Information
11.13.2 NeoGenomics Laboratories Overview
11.13.3 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 NeoGenomics Laboratories Recent Developments
11.14 Opko Health
11.14.1 Opko Health Corporation Information
11.14.2 Opko Health Overview
11.14.3 Opko Health MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Opko Health MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Opko Health Recent Developments
11.15 Quest Diagnostics
11.15.1 Quest Diagnostics Corporation Information
11.15.2 Quest Diagnostics Overview
11.15.3 Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Quest Diagnostics Recent Developments
11.16 Sysmex Corporation
11.16.1 Sysmex Corporation Corporation Information
11.16.2 Sysmex Corporation Overview
11.16.3 Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sysmex Corporation Recent Developments
11.17 Adaptive Biotechnologies
11.17.1 Adaptive Biotechnologies Corporation Information
11.17.2 Adaptive Biotechnologies Overview
11.17.3 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Adaptive Biotechnologies Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 MRD (Minimal Residual Disease) Testing Industry Chain Analysis
12.2 MRD (Minimal Residual Disease) Testing Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 MRD (Minimal Residual Disease) Testing Production Mode & Process
12.4 MRD (Minimal Residual Disease) Testing Sales and Marketing
12.4.1 MRD (Minimal Residual Disease) Testing Sales Channels
12.4.2 MRD (Minimal Residual Disease) Testing Distributors
12.5 MRD (Minimal Residual Disease) Testing Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 MRD (Minimal Residual Disease) Testing Industry Trends
13.2 MRD (Minimal Residual Disease) Testing Market Drivers
13.3 MRD (Minimal Residual Disease) Testing Market Challenges
13.4 MRD (Minimal Residual Disease) Testing Market Restraints
14 Key Findings in The Global MRD (Minimal Residual Disease) Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figures, Tables and Charts Available in Global MRD (Minimal Residual Disease) Testing Market Insights, Forecast to 2028
List of TablesTable 1. Global MRD (Minimal Residual Disease) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Flow Cytometry
Table 3. Major Manufacturers of Polymerase Chain Reaction (PCR)
Table 4. Major Manufacturers of Next-Generation Sequencing (NGS)
Table 5. Global MRD (Minimal Residual Disease) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global MRD (Minimal Residual Disease) Testing Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global MRD (Minimal Residual Disease) Testing Sales by Region (2017-2022) & (Units)
Table 8. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2017-2022)
Table 9. Global MRD (Minimal Residual Disease) Testing Sales by Region (2023-2028) & (Units)
Table 10. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2023-2028)
Table 11. Global MRD (Minimal Residual Disease) Testing Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2017-2022)
Table 13. Global MRD (Minimal Residual Disease) Testing Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2023-2028)
Table 15. Global MRD (Minimal Residual Disease) Testing Sales by Manufacturers (2017-2022) & (Units)
Table 16. Global MRD (Minimal Residual Disease) Testing Sales Share by Manufacturers (2017-2022)
Table 17. Global MRD (Minimal Residual Disease) Testing Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global MRD (Minimal Residual Disease) Testing Revenue Share by Manufacturers (2017-2022)
Table 19. MRD (Minimal Residual Disease) Testing Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global MRD (Minimal Residual Disease) Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global MRD (Minimal Residual Disease) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MRD (Minimal Residual Disease) Testing as of 2021)
Table 22. MRD (Minimal Residual Disease) Testing Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers MRD (Minimal Residual Disease) Testing Product Offered
Table 24. Date of Manufacturers Enter into MRD (Minimal Residual Disease) Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units)
Table 27. Global MRD (Minimal Residual Disease) Testing Sales by Type (2023-2028) & (Units)
Table 28. Global MRD (Minimal Residual Disease) Testing Sales Share by Type (2017-2022)
Table 29. Global MRD (Minimal Residual Disease) Testing Sales Share by Type (2023-2028)
Table 30. Global MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global MRD (Minimal Residual Disease) Testing Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global MRD (Minimal Residual Disease) Testing Revenue Share by Type (2017-2022)
Table 33. Global MRD (Minimal Residual Disease) Testing Revenue Share by Type (2023-2028)
Table 34. MRD (Minimal Residual Disease) Testing Price by Type (2017-2022) & (US$/Unit)
Table 35. Global MRD (Minimal Residual Disease) Testing Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units)
Table 37. Global MRD (Minimal Residual Disease) Testing Sales by Application (2023-2028) & (Units)
Table 38. Global MRD (Minimal Residual Disease) Testing Sales Share by Application (2017-2022)
Table 39. Global MRD (Minimal Residual Disease) Testing Sales Share by Application (2023-2028)
Table 40. Global MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global MRD (Minimal Residual Disease) Testing Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global MRD (Minimal Residual Disease) Testing Revenue Share by Application (2017-2022)
Table 43. Global MRD (Minimal Residual Disease) Testing Revenue Share by Application (2023-2028)
Table 44. MRD (Minimal Residual Disease) Testing Price by Application (2017-2022) & (US$/Unit)
Table 45. Global MRD (Minimal Residual Disease) Testing Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units)
Table 47. North America MRD (Minimal Residual Disease) Testing Sales by Type (2023-2028) & (Units)
Table 48. North America MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America MRD (Minimal Residual Disease) Testing Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units)
Table 51. North America MRD (Minimal Residual Disease) Testing Sales by Application (2023-2028) & (Units)
Table 52. North America MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America MRD (Minimal Residual Disease) Testing Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022) & (Units)
Table 55. North America MRD (Minimal Residual Disease) Testing Sales by Country (2023-2028) & (Units)
Table 56. North America MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America MRD (Minimal Residual Disease) Testing Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units)
Table 59. Europe MRD (Minimal Residual Disease) Testing Sales by Type (2023-2028) & (Units)
Table 60. Europe MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe MRD (Minimal Residual Disease) Testing Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units)
Table 63. Europe MRD (Minimal Residual Disease) Testing Sales by Application (2023-2028) & (Units)
Table 64. Europe MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe MRD (Minimal Residual Disease) Testing Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022) & (Units)
Table 67. Europe MRD (Minimal Residual Disease) Testing Sales by Country (2023-2028) & (Units)
Table 68. Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units)
Table 71. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Type (2023-2028) & (Units)
Table 72. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units)
Table 75. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Application (2023-2028) & (Units)
Table 76. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Region (2017-2022) & (Units)
Table 79. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Region (2023-2028) & (Units)
Table 80. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units)
Table 83. Latin America MRD (Minimal Residual Disease) Testing Sales by Type (2023-2028) & (Units)
Table 84. Latin America MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America MRD (Minimal Residual Disease) Testing Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units)
Table 87. Latin America MRD (Minimal Residual Disease) Testing Sales by Application (2023-2028) & (Units)
Table 88. Latin America MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America MRD (Minimal Residual Disease) Testing Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022) & (Units)
Table 91. Latin America MRD (Minimal Residual Disease) Testing Sales by Country (2023-2028) & (Units)
Table 92. Latin America MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America MRD (Minimal Residual Disease) Testing Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units)
Table 95. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Type (2023-2028) & (Units)
Table 96. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units)
Table 99. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Application (2023-2028) & (Units)
Table 100. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022) & (Units)
Table 103. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Country (2023-2028) & (Units)
Table 104. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2023-2028) & (US$ Million)
Table 106. ICON plc Corporation Information
Table 107. ICON plc Description and Major Businesses
Table 108. ICON plc MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. ICON plc MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. ICON plc Recent Developments
Table 111. ArcherDX(Invitae) Corporation Information
Table 112. ArcherDX(Invitae) Description and Major Businesses
Table 113. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. ArcherDX(Invitae) Recent Developments
Table 116. ARUP Laboratories Corporation Information
Table 117. ARUP Laboratories Description and Major Businesses
Table 118. ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. ARUP Laboratories Recent Developments
Table 121. Asuragen Corporation Information
Table 122. Asuragen Description and Major Businesses
Table 123. Asuragen MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Asuragen MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Asuragen Recent Developments
Table 126. Cergentis B.V. Corporation Information
Table 127. Cergentis B.V. Description and Major Businesses
Table 128. Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Cergentis B.V. Recent Developments
Table 131. Bio-Rad Laboratories Corporation Information
Table 132. Bio-Rad Laboratories Description and Major Businesses
Table 133. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Bio-Rad Laboratories Recent Developments
Table 136. Mission Bio Corporation Information
Table 137. Mission Bio Description and Major Businesses
Table 138. Mission Bio MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Mission Bio MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Mission Bio Recent Developments
Table 141. Guardant Health Corporation Information
Table 142. Guardant Health Description and Major Businesses
Table 143. Guardant Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Guardant Health MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Guardant Health Recent Developments
Table 146. Invivoscribe Corporation Information
Table 147. Invivoscribe Description and Major Businesses
Table 148. Invivoscribe MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Invivoscribe MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Invivoscribe Recent Developments
Table 151. LabCorp Corporation Information
Table 152. LabCorp Description and Major Businesses
Table 153. LabCorp MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. LabCorp MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. LabCorp Recent Developments
Table 156. Inivata Corporation Information
Table 157. Inivata Description and Major Businesses
Table 158. Inivata MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. Inivata MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Inivata Recent Developments
Table 161. Natera Corporation Information
Table 162. Natera Description and Major Businesses
Table 163. Natera MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 164. Natera MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Natera Recent Developments
Table 166. NeoGenomics Laboratories Corporation Information
Table 167. NeoGenomics Laboratories Description and Major Businesses
Table 168. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 169. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. NeoGenomics Laboratories Recent Developments
Table 171. Opko Health Corporation Information
Table 172. Opko Health Description and Major Businesses
Table 173. Opko Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 174. Opko Health MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Opko Health Recent Developments
Table 176. Quest Diagnostics Corporation Information
Table 177. Quest Diagnostics Description and Major Businesses
Table 178. Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 179. Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Quest Diagnostics Recent Developments
Table 181. Sysmex Corporation Corporation Information
Table 182. Sysmex Corporation Description and Major Businesses
Table 183. Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 184. Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 185. Sysmex Corporation Recent Developments
Table 186. Adaptive Biotechnologies Corporation Information
Table 187. Adaptive Biotechnologies Description and Major Businesses
Table 188. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 189. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 190. Adaptive Biotechnologies Recent Developments
Table 191. Key Raw Materials Lists
Table 192. Raw Materials Key Suppliers Lists
Table 193. MRD (Minimal Residual Disease) Testing Distributors List
Table 194. MRD (Minimal Residual Disease) Testing Customers List
Table 195. MRD (Minimal Residual Disease) Testing Market Trends
Table 196. MRD (Minimal Residual Disease) Testing Market Drivers
Table 197. MRD (Minimal Residual Disease) Testing Market Challenges
Table 198. MRD (Minimal Residual Disease) Testing Market Restraints
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. MRD (Minimal Residual Disease) Testing Product Picture
Figure 3. Global MRD (Minimal Residual Disease) Testing Market Share by Type in 2021 & 2028
Figure 3. Flow Cytometry Product Picture
Figure 4. Polymerase Chain Reaction (PCR) Product Picture
Figure 5. Next-Generation Sequencing (NGS) Product Picture
Figure 6. Global MRD (Minimal Residual Disease) Testing Market Share by Application in 2021 & 2028
Figure 7. Specialty Clinics and Hospitals
Figure 8. Diagnostic Laboratories
Figure 9. Research Institutions
Figure 10. MRD (Minimal Residual Disease) Testing Report Years Considered
Figure 11. Global MRD (Minimal Residual Disease) Testing Sales 2017-2028 (Units)
Figure 12. Global MRD (Minimal Residual Disease) Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global MRD (Minimal Residual Disease) Testing Revenue 2017-2028 (US$ Million)
Figure 14. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2017-2022)
Figure 16. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2023-2028)
Figure 17. North America MRD (Minimal Residual Disease) Testing Sales YoY (2017-2028) & (Units)
Figure 18. North America MRD (Minimal Residual Disease) Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe MRD (Minimal Residual Disease) Testing Sales YoY (2017-2028) & (Units)
Figure 20. Europe MRD (Minimal Residual Disease) Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales YoY (2017-2028) & (Units)
Figure 22. Asia-Pacific MRD (Minimal Residual Disease) Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America MRD (Minimal Residual Disease) Testing Sales YoY (2017-2028) & (Units)
Figure 24. Latin America MRD (Minimal Residual Disease) Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales YoY (2017-2028) & (Units)
Figure 26. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The MRD (Minimal Residual Disease) Testing Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of MRD (Minimal Residual Disease) Testing in the World: Market Share by MRD (Minimal Residual Disease) Testing Revenue in 2021
Figure 29. Global MRD (Minimal Residual Disease) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028)
Figure 31. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028)
Figure 32. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028)
Figure 33. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028)
Figure 34. North America MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028)
Figure 35. North America MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028)
Figure 36. North America MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028)
Figure 37. North America MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028)
Figure 38. North America MRD (Minimal Residual Disease) Testing Sales Share by Country (2017-2028)
Figure 39. North America MRD (Minimal Residual Disease) Testing Revenue Share by Country (2017-2028)
Figure 40. United States MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 41. Canada MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 42. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028)
Figure 43. Europe MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028)
Figure 44. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028)
Figure 45. Europe MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028)
Figure 46. Europe MRD (Minimal Residual Disease) Testing Sales Share by Country (2017-2028)
Figure 47. Europe MRD (Minimal Residual Disease) Testing Revenue Share by Country (2017-2028)
Figure 48. Germany MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 49. France MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 51. Italy MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 52. Russia MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific MRD (Minimal Residual Disease) Testing Sales Share by Region (2017-2028)
Figure 58. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue Share by Region (2017-2028)
Figure 59. China MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 60. Japan MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 62. India MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 63. Australia MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028)
Figure 69. Latin America MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028)
Figure 70. Latin America MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028)
Figure 71. Latin America MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028)
Figure 72. Latin America MRD (Minimal Residual Disease) Testing Sales Share by Country (2017-2028)
Figure 73. Latin America MRD (Minimal Residual Disease) Testing Revenue Share by Country (2017-2028)
Figure 74. Mexico MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue Share by Country (2017-2028)
Figure 83. Turkey MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 85. UAE MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million)
Figure 86. MRD (Minimal Residual Disease) Testing Value Chain
Figure 87. MRD (Minimal Residual Disease) Testing Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Keyplayers in Global MRD (Minimal Residual Disease) Testing Market Insights, Forecast to 2028
ICON plcArcherDX(Invitae)
ARUP Laboratories
Asuragen
Cergentis B.V.
Bio-Rad Laboratories
Mission Bio
Guardant Health
Invivoscribe
LabCorp
Inivata
Natera
NeoGenomics Laboratories
Opko Health
Quest Diagnostics
Sysmex Corporation
Adaptive Biotechnologies